Measuring vascularity of hypertrophic scars by dermoscopy: Construct validity and predictive ability of scar thickness change

血管性 医学 疤痕 增生性瘢痕 增生性瘢痕 红斑 超声波 外科 放射科
作者
Huan Deng,Cecilia W. P. Li-Tsang,Jingbo Li
出处
期刊:Skin Research and Technology [Wiley]
卷期号:26 (3): 369-375 被引量:5
标识
DOI:10.1111/srt.12812
摘要

Abstract Background Vascularity of hypertrophic scar is a key indicator of scar maturation and a vital parameter of evaluating effects of scar management interventions. This study aims to explore the construct validity of dermoscopy for measuring vascularity of hypertrophic scar and its predictive ability of scar thickness change. Methods Patients with hypertrophic scars were recruited for scar assessments at baseline and at one‐month follow‐up, which consisted of the Patient and Observer Scar Assessment Scale, DermaLab Combo, ultrasound and dermoscopy. Results Forty hypertrophic scars in the active proliferation stage were included in this study. The dermoscopic measurements based on color significantly discriminated the hypertrophic scars from the healthy skin ( P < .001). In addition, they showed moderate to strong correlations with the vascularity component of the Patient and Observer Scar Assessment Scale ( r = −.438, P < .01; r = −.461, P < .01; and r = −.437, P < .01) and the erythema value as measured by DermaLab Combo ( r = −.474, P < .01; r = −.603, P < .01; and r = −.498, P < .01). Weak to moderate correlations of the micro‐vessel percentage were observed with the vascularity of Patient and Observer Scar Assessment Scale ( r = .385, P < .01) and the erythema of DermaLab Combo ( r = .444, P < .01). For prediction of the scars with high risk of thickness change, the green value by dermoscopy was the strongest predictor (AUC = 0.738, P = .034, 95%CI = 0.570‐0.906). Conclusion Dermoscopy, which evaluates scar vascularity by measuring scar color and micro‐vessel percentage, could be used as an objective assessment tool to indicate scar maturation and identify scars with active proliferation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
充电宝应助Eternity2025采纳,获得10
刚刚
刚刚
1秒前
吉田清子发布了新的文献求助10
1秒前
1秒前
田振扬完成签到,获得积分10
2秒前
jsh完成签到,获得积分10
2秒前
甜甜亦丝完成签到,获得积分10
2秒前
欧清完成签到,获得积分10
2秒前
parpate发布了新的文献求助10
3秒前
Owen应助林途采纳,获得10
5秒前
5秒前
renren发布了新的文献求助10
5秒前
关晚竹完成签到,获得积分20
6秒前
科研通AI5应助HughWang采纳,获得30
6秒前
7秒前
7秒前
10秒前
CipherSage应助关晚竹采纳,获得10
13秒前
13秒前
今天想要吃饭完成签到,获得积分10
14秒前
柊苒发布了新的文献求助10
15秒前
16秒前
16秒前
16秒前
AskNature完成签到,获得积分10
16秒前
孙颢然完成签到 ,获得积分10
17秒前
17秒前
陶醉雪青应助科研通管家采纳,获得10
18秒前
bkagyin应助科研通管家采纳,获得10
18秒前
烟花应助科研通管家采纳,获得10
18秒前
Tourist应助科研通管家采纳,获得10
18秒前
酷波er应助科研通管家采纳,获得10
18秒前
研友_VZG7GZ应助科研通管家采纳,获得10
18秒前
顾矜应助科研通管家采纳,获得10
18秒前
科研通AI5应助科研通管家采纳,获得10
19秒前
星辰大海应助科研通管家采纳,获得10
19秒前
lilili应助科研通管家采纳,获得10
19秒前
在水一方应助科研通管家采纳,获得10
19秒前
Lucas应助科研通管家采纳,获得10
19秒前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Handbook of Social and Emotional Learning 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5134862
求助须知:如何正确求助?哪些是违规求助? 4335512
关于积分的说明 13506957
捐赠科研通 4173083
什么是DOI,文献DOI怎么找? 2288120
邀请新用户注册赠送积分活动 1288949
关于科研通互助平台的介绍 1229971